Fig. 2From: SARS-CoV-2 antibody seroprevalence in Togo: a national cross-sectional household survey, May–June, 2021Factors associated with the presence of anti-SARS-CoV-2 antibodies, final multivariate models, Sero-CoV Togo survey, March – June 2021 (A- whole sample (N = 7593), B-vaccinated subjects (N = 1316), C- unvaccinated subjects (N = 4924)). *The final multivariable model for B is better adjusted without the age variableBack to article page